Cargando…
The resurgence of estrogens in the treatment of castration-resistant prostate cancer
Use of exogenous estrogens in manipulating the androgenestrogen equilibrium was one of the earliest therapeutic strategies developed to treat prostate cancer which followed close on heels the discovery of hormone dependence of this tumor. Despite its well-documented benefit, estrogen therapy fell ou...
Autores principales: | Moorthy, H. Krishna, Laxman Prabhu, G. G., Venugopal, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639989/ https://www.ncbi.nlm.nih.gov/pubmed/31367069 http://dx.doi.org/10.4103/iju.IJU_56_19 |
Ejemplares similares
-
Clinical and therapeutic implications of sex steroid hormone receptor status in urothelial bladder cancer
por: Moorthy, H. Krishna, et al.
Publicado: (2020) -
Strategies for prostate cancer prevention: Review of the literature
por: Moorthy, H. Krishna, et al.
Publicado: (2008) -
Prospects of estrogen receptor β activation in the treatment of castration-resistant prostate cancer
por: Gehrig, Julia, et al.
Publicado: (2017) -
New developments in the treatment of castration resistant prostate cancer
por: Wadia, Roxanne, et al.
Publicado: (2014) -
Treatment sequencing in metastatic castrate-resistant prostate cancer
por: Sartor, Oliver, et al.
Publicado: (2014)